Found 1872 clinical trials
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Hematology
-
Currently Recruiting
PANOVA-3 (Pancreatic Adenocarcinoma)
People with pancreatic adenocarcinoma are asked to participate in a research study being conducted by White Plains Hospital.
- 12 views
- 02 Aug, 2019
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
CALLA - Cervical Cancer
People with cervical cancer are asked to participate in a research study being conducted by Northwell Health.
- 15 views
- 02 Aug, 2019
- 1 location
-
Phase 2 trial
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
Pancreatic Adenocarcinoma - Advanced
Pancreatic Adenocarcinoma - Advanced
- 150 views
- 08 Nov, 2020
- 1 location
-
Phase 2 trial
-
Accepting pediatric ages
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
- 178 views
- 23 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
- 178 views
- 24 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
- 182 views
- 24 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
Newly diagnosed prostate cancer
People with newly diagnosed prostate cancer are asked to participate in a research study being conducted by NYC Health +Hospitals
- 109 views
- 01 May, 2020
- 1 location
-
Phase 3 trial
-
Accepting pediatric ages
-
Currently Recruiting
RTOG 1010: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma
RTOG 1010: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma
- 230 views
- 08 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
HER2 Negative Advanced Breast Cancer
People with HER2 negative advanced breast cancer are asked to participate in a research study being conducted by Queens Hospital Center.
- 27 views
- 28 Oct, 2019
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
EMERALD – Breast Cancer
People with breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center.
- 54 views
- 23 Nov, 2020
- 1 location